- Home
- HSLV vs CYRX Comparison
HSLV vs CYRX Comparison
Compare HSLV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HSLV | CYRX |
|---|---|---|
| Founded | N/A | 1999 |
| Country | Canada | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 893.0M | 774.7M |
| IPO Year | 2024 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HSLV | CYRX |
|---|---|---|
| Price | $5.17 | $15.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 361.3K | ★ 609.8K |
| Earning Date | 05-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $37.60 | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.88 | $7.61 |
| 52 Week High | $6.77 | $16.89 |
Technical Indicators
Market Signals| Indicator | HSLV | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.64 | 48.67 |
| Support Level | $5.08 | $14.60 |
| Resistance Level | $5.28 | $15.60 |
| Average True Range (ATR) | 0.23 | 0.59 |
| MACD | 0.11 | -0.06 |
| Stochastic Oscillator | 72.73 | 61.40 |
Price Performance
Historical ComparisonAbout HSLV Highlander Silver Corp. Common Shares
Highlander Silver Corp. is a mineral exploration company engaged in the acquisition, exploration and evaluation of mineral properties located in Peru. It is focused on advancing the bonanza grade San Luis gold-silver project that is located in Central Peru. The company has determined that it has one operating segment, being the exploration of mineral properties.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.